Christie Thomas, MD
Nephrology · Iowa City, IANPI 1760470611
Payments from drug & device makers
What this record shows
This record is dominated by education: $5 of the $5 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Travere Therapeutics, Inc.. That places this record below the midpoint for nephrology clinicians in IA, where the typical reported total is $192.
Across 3 payments — averaging $1.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$5
Across 16 payments — averaging $7995.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$60K
- Shire North American Group Inc$39K
- Sanofi US Services Inc.$19K
- Takeda Pharmaceuticals U.S.A., Inc.$11K
What the payments were for
- Education$5100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 3 | $5 |
How this compares
$5 in reported general payments places this provider in the 15th percentile of 73 nephrology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CystaranCysteamine Hcl | 15 | $115,219 |
| Everolimus | 21 | $35,387 |
| LokelmaSodium Zirconium Cyclosilicate | 13 | $10,370 |
| Valganciclovir Hcl | 34 | $10,142 |
| FarxigaDapagliflozin Propanediol | 17 | $8,988 |
| Atovaquone | 12 | $5,468 |
| Tacrolimus | 25 | $3,737 |
| Mycophenolate Mofetil | 30 | $1,874 |
| Cinacalcet Hcl | 20 | $1,798 |
| Potassium Chloride | 42 | $1,775 |
| LevocarnitineLevocarnitine (With Sugar) | 13 | $1,774 |
| Nifedipine ErNifedipine | 71 | $666 |
| Carvedilol | 69 | $375 |
| Prednisone | 97 | $331 |
| Tamsulosin Hcl | 50 | $276 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Iowa City
- Lawrence HunsickerIowa City$70K
- Lama NoureddineIowa City$7K
- Benjamin GriffinIowa City$6K
- Mony FraerIowa City$5K
- Kantima PhisitkulIowa City$432
- Masaaki YamadaIowa City$271
- Waleed HassanIowa City$203
- Shahed AmmarIowa City$132
- Bahjat AzriehIowa City$119
- Timothy ChowIowa City$106
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.